Related Experiment Videos
Calciphylaxis: a case report
D Strippoli1, V Simonetti, G Russo
1Department of Dermatology, Alessandro Manzoni Hospital, Lecco, Italy.
Insights
Calciphylaxis, a severe vascular condition, involves calcification and thrombosis leading to tissue damage, particularly in the limbs. Prevention through managing kidney failure, hyperparathyroidism, and diabetes is key.
Area of Science:
- Vascular Medicine
- Dermatology
- Nephrology
Background:
- Calciphylaxis, or calcific uremic arteriolopathy, is a rare and severe condition affecting the skin and subcutaneous tissues.
- It is characterized by calcification and thrombosis of small arteries and arterioles, leading to tissue ischemia and necrosis.
Observation:
- The condition primarily impacts the tunica elastica of the reticular or deep subcutaneous dermis.
- Affected areas commonly include torso muscles, the lumbar region, and lower limbs.
- The exact pathogenesis remains unknown, but associations with hyperparathyroidism, chronic renal failure, and diabetes mellitus are noted.
Findings:
- Calciphylaxis presents with vascular calcifications and thrombosis, resulting in painful skin necrosis.
- Extravascular calcification can also occur, contributing to the disease's severity.
- Associated conditions include chronic kidney disease, diabetes, and hyperparathyroidism.
Implications:
- Early recognition and management of underlying conditions like renal failure, hyperparathyroidism, and diabetes are crucial for prevention.
- Surgical debridement of necrotic tissue may be necessary.
- Avoiding potential trigger factors, such as systemic corticosteroids, is recommended.
Abstract:
Calciphylaxis or calcific uremic arteriolopathy is characterized by the involvement of the tunica elastica of the reticular or deep subcutaneous dermis, with extravascular and vascular thrombosis calcifications that lead to tissular ischemia. The torso muscles, the lumbar region, and lower limbs are more frequently affected. The pathogenesis is unknown. Calciphylaxis is associated to hyperparathyroidism, chronic renal failure, and diabetes mellitus. The best therapy to date is prevention: early treatment of renal failure, performing a partial parathyroidectomy where necessary, surgical debridement of the necrotic tissue, as well as avoiding the trigger factors such as systemic corticosteroids.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Rocky Mountain Spotted Fever
Hypersensitivity Reactions: Immune-Complex Reactions
Graves Disease II: Pathophysiology
Nephrotic Syndrome II : Assessment and Medical Management